Day: December 19, 2021

Jerusalem Post: Israeli co. kicks off COVID oral vaccine trial in South Africa

The first volunteer in a Phase I clinical trial of an oral COVID-19 vaccine developed by an Israeli-American company has been screened and enrolled, according to Oravax Medical, a subsidiary of Oramed Pharmaceuticals. The trial is taking place in South Africa. Read more here.

  • +1-844-9-ORAMED
  • office@oramed.com
  • 1185 Avenue of the Americas, New York, NY 10036 USA
Linkedin-in Facebook-f Twitter Youtube

Copyright © 2022 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy

Join our mailing list

  • +1-844-9-ORAMED
  • office@oramed.com
Linkedin-in Facebook-f Twitter Youtube
Home
About
Technology
Pipeline
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
INVESTORS
Corporate presentation
Investor Relations
SEC filings
Investor FAQ
Governance documents
Investor tools
ANNUAL SHAREHOLDER MEETING
Oravax Medical
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset